P, they will get another chance to submit an NDA but it depends on the reason for any subsequent CRL. A ruling against same product class rulings might be damning. A ruling against non-abuse deterrent IR products obviously now. So there is no extra cost concern here.
Preparing a quality NDA re-submission is an outcome of the CRL and not the use of an Advisory Committee.
What has perhaps cost us a little is that its taken a little longer to lockdown the path to approval. It was anticipated we would have the NDA re-submitted by end 2012. Looks like we will re-submit in Feb, a 1 to 2 month delay. Not that bad but yes, it has a cost.
On a different topic, trading has settled a little. Nice to see us holding the 100c level. The charts all look a lot better now too. Way off the overbought position we've been in recently. The weekly and monthly 5 year charts look great actually.
Have a nice weekend mate. Lets hope for another good one next week.
QRX Price at posting:
$1.00 Sentiment: Buy Disclosure: Held